-
公开(公告)号：US20080242654A1
公开(公告)日：2008-10-02
申请号：US12051538
申请日：2008-03-19
申请人： Teodozyj Kolasa , Jennifer M. Frost , Meena V. Patel , Steven P. Latshaw , Arturo Perez-Medrano , Xueqing Wang , Sridhar Peddi , William A. Carroll , Michael J. Dart
发明人： Teodozyj Kolasa , Jennifer M. Frost , Meena V. Patel , Steven P. Latshaw , Arturo Perez-Medrano , Xueqing Wang , Sridhar Peddi , William A. Carroll , Michael J. Dart
IPC分类号： C07D277/18 , A61K31/426 , A61K31/397 , A61K31/4436 , C07D417/02 , A61K31/5377 , A61K31/4535 , A61P11/00 , A61P9/00 , A61P25/00 , A61P35/00 , A61P37/00
CPC分类号： C07D277/46 , C07D417/06 , C07D417/12 , C07D513/04 , Y02P20/582
摘要： The present application relates to thiazolylidene containing compounds of formula (I) wherein R1, R2, R3, R4, L2 and A are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
摘要翻译： 本申请涉及式（I）的含噻唑基的化合物，其中R 1，R 2，R 3，R 4， / SUB>，L 2＆gt;和A如说明书中所定义。 还公开了包含这些化合物的组合物，以及使用这些化合物和组合物治疗病症和障碍的方法。
-
公开(公告)号：US06495576B2
公开(公告)日：2002-12-17
申请号：US10046465
申请日：2002-01-14
申请人： Michael E. Kort , Robert J. Gregg , William A. Carroll , Arturo Perez Medrano , Jürgen Dinges , Fatima Z. Basha
发明人： Michael E. Kort , Robert J. Gregg , William A. Carroll , Arturo Perez Medrano , Jürgen Dinges , Fatima Z. Basha
IPC分类号： A61K3144
CPC分类号： C07D213/74 , C07C233/78 , C07C2601/04 , C07D213/75 , C07D213/76 , C07D213/81 , C07D213/82 , C07D241/20 , C07D405/12 , C07D409/12
摘要： Compounds of formula (I) may be useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal
摘要翻译： 式（I）化合物可用于治疗用钾通道开放剂预防或改善的疾病。 还公开了钾通道开放组合物和在哺乳动物中开放钾通道的方法
-
公开(公告)号：US08921514B2
公开(公告)日：2014-12-30
申请号：US12964027
申请日：2010-12-09
申请人： David A. DeGoey , Warren M. Kati , Charles W. Hutchins , Pamela L. Donner , Allan C. Krueger , John T. Randolph , Christopher E. Motter , Lissa T. Nelson , Sachin V. Patel , Mark A. Matulenko , Ryan G. Keddy , Tammie K. Jinkerson , Yi Gao , Dachun Liu , John K. Pratt , Todd W. Rockway , Clarence J. Maring , Douglas K. Hutchinson , Charles A. Flentge , Rolf Wagner , Michael D. Tufano , David A. Betebenner , Kathy Sarris , Kevin R. Woller , Seble H. Wagaw , Jean C. Califano , Wenke Li , Daniel D. Caspi , Mary E. Bellizzi , William A. Carroll
发明人： David A. DeGoey , Warren M. Kati , Charles W. Hutchins , Pamela L. Donner , Allan C. Krueger , John T. Randolph , Christopher E. Motter , Lissa T. Nelson , Sachin V. Patel , Mark A. Matulenko , Ryan G. Keddy , Tammie K. Jinkerson , Yi Gao , Dachun Liu , John K. Pratt , Todd W. Rockway , Clarence J. Maring , Douglas K. Hutchinson , Charles A. Flentge , Rolf Wagner , Michael D. Tufano , David A. Betebenner , Kathy Sarris , Kevin R. Woller , Seble H. Wagaw , Jean C. Califano , Wenke Li , Daniel D. Caspi , Mary E. Bellizzi , William A. Carroll
IPC分类号： A61K31/66 , C07K16/00 , C07D453/00 , C07D401/14 , C07D403/14 , C07D405/14 , C07D413/14 , C07D491/113
CPC分类号： C07F9/65583 , C07C33/26 , C07C201/06 , C07C205/19 , C07D207/08 , C07D207/09 , C07D207/16 , C07D401/14 , C07D403/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D453/00 , C07D471/04 , C07D491/113 , C07K5/06
摘要： Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
-
公开(公告)号：US08835475B2
公开(公告)日：2014-09-16
申请号：US12967282
申请日：2010-12-14
申请人： William A. Carroll , Michael J. Dart , Teodozyj Kolasa , Tongmei Li , Derek W. Nelson , Meena Patel , Sridhar Peddi , Arturo Perez-Medrano , Xueqing Wang
发明人： William A. Carroll , Michael J. Dart , Teodozyj Kolasa , Tongmei Li , Derek W. Nelson , Meena Patel , Sridhar Peddi , Arturo Perez-Medrano , Xueqing Wang
IPC分类号： A61K31/425 , A61K31/5377 , A61K31/4725 , A61K31/4436 , A61K31/429 , A61K31/427
CPC分类号： A61K31/425 , A61K31/427 , A61K31/429 , A61K31/4436 , A61K31/4725 , A61K31/5377 , C07D275/02 , C07D275/04 , C07D417/04 , C07D417/06 , C07D417/12 , C07D513/04 , C07D513/10 , Y02P20/582
摘要： The present application relates to isothiazolylidene containing compounds of Formula (I) wherein R1, R2, R3, R4, and L are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译： 本申请涉及含有异噻唑基的式（I）化合物，其中R 1，R 2，R 3，R 4和L如说明书中所定义，包含这些化合物的组合物，以及使用这些化合物和组合物治疗病症和障碍的方法。
-
公开(公告)号：US08546583B2
公开(公告)日：2013-10-01
申请号：US11755434
申请日：2007-05-30
申请人： Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
发明人： Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
IPC分类号： A61K31/426 , A61K31/427 , C07D417/06 , C07D417/14 , C07D277/44
CPC分类号： C07D277/82 , C07D277/46 , C07D277/48 , C07D277/60 , C07D417/06 , C07D417/12 , C07D477/14 , C07D513/04
摘要： The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L1 are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1a, R2a and (Rx)n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译： 本发明涉及式（I）化合物或其药物盐，前体药物，前体药物或其组合的盐，其中R1，R2，R3，R4和L1在说明书中定义，包含这些化合物的组合物和方法 使用这些化合物和组合物治疗病症和病症。 本发明还涉及式（II）化合物或其药物盐，前药，前体药物或其组合的盐，其中R 1a，R 2a和（R x）n如说明书中所定义，包含这些化合物的组合物和方法 使用这些化合物和组合物治疗病症和病症。
-
公开(公告)号：US20120329772A1
公开(公告)日：2012-12-27
申请号：US13544387
申请日：2012-07-09
申请人： William A. Carroll , Arturo Perez-Medrano , Alan S. Florjancic , Derek W. Nelson , Sridhar Peddi , Tongmei Li , Eric M. Bunnelle , Gavin Hirst , Biqin C. Li
发明人： William A. Carroll , Arturo Perez-Medrano , Alan S. Florjancic , Derek W. Nelson , Sridhar Peddi , Tongmei Li , Eric M. Bunnelle , Gavin Hirst , Biqin C. Li
IPC分类号： C07D257/06 , C07D413/12 , A61K31/5377 , C07D401/12 , A61K31/4439 , A61K31/4709 , C07D409/12 , C07D403/12 , A61K31/497 , A61K31/4155 , A61K31/435 , C07D405/12 , A61K31/496 , C07D491/048 , A61K31/4355 , C07D417/12 , A61K31/427 , A61K31/506 , C07D401/14 , A61K31/444 , C07D413/14 , A61K31/551 , A61K31/55 , A61K31/553 , C07D487/04 , A61P29/00 , A61P25/28 , A61P25/24 , A61P25/00 , A61K31/41
CPC分类号： C07D487/04 , C07D257/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D487/08 , C07D491/04 , C07D491/048 , C07D491/08
摘要： A compound having Formula (I) or Formula (II) is disclosed as an P2X7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R1, R2, R3, R4, and R5, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X7 are also disclosed.
摘要翻译： 公开了具有式（I）或式（II）的化合物作为P2X7拮抗剂，其中A，B，C，Y，Y，Z，m，v，R 1，R 2，R 3，R 4和R 5如 在说明中。 还公开了用于治疗由P2X7调节的疾病或病症的方法和组合物。
-
37.发明授权Method for reducing side effects of CB2 receptor agonist therapy using a combination of a selective CB2 receptor agonist and a selective CB1 receptor antagonist 有权使用选择性CB2受体激动剂和选择性CB1受体拮抗剂的组合来减少CB2受体激动剂治疗的副作用的方法公开(公告)号：US08044071B2
公开(公告)日：2011-10-25
申请号：US12252811
申请日：2008-10-16
申请人： William A. Carroll
发明人： William A. Carroll
IPC分类号： A61K31/4453 , A61K31/426
CPC分类号： A61K31/427 , A61K31/44 , A61K31/454
摘要： The present application describes a method of treating pain with a combination of a CB2 cannabinoid receptor agonist and rimonabast.
摘要翻译： 本申请描述了一种用CB2大麻素受体激动剂和利莫法汀组合治疗疼痛的方法。
-
公开(公告)号：US20110207699A1
公开(公告)日：2011-08-25
申请号：US12964027
申请日：2010-12-09
申请人： David A. DeGoey , Warren M. Kati , Charles W. Hutchins , Pamela L. Donner , Allan C. Krueger , John T. Randolph , Christopher E. Motter , Lissa T. Nelson , Sachin V. Patel , Mark A. Matulenko , Ryan G. Keddy , Tammie K. Jinkerson , Todd N. Soltwedel , Douglas K. Hutchinson , Charles A. Flentge , Rolf Wagner , Clarence J. Maring , Michael D. Tufano , David A. Betebenner , Todd W. Rockway , Dachun Liu , John K. Pratt , Michael J. Lavin , Kathy Sarris , Kevin R. Woller , Seble H. Wagaw , Jean C. Califano , Wenke Li , Daniel D. Caspi , Mary E. Bellizzi , William A. Carroll
发明人： David A. DeGoey , Warren M. Kati , Charles W. Hutchins , Pamela L. Donner , Allan C. Krueger , John T. Randolph , Christopher E. Motter , Lissa T. Nelson , Sachin V. Patel , Mark A. Matulenko , Ryan G. Keddy , Tammie K. Jinkerson , Todd N. Soltwedel , Douglas K. Hutchinson , Charles A. Flentge , Rolf Wagner , Clarence J. Maring , Michael D. Tufano , David A. Betebenner , Todd W. Rockway , Dachun Liu , John K. Pratt , Michael J. Lavin , Kathy Sarris , Kevin R. Woller , Seble H. Wagaw , Jean C. Califano , Wenke Li , Daniel D. Caspi , Mary E. Bellizzi , William A. Carroll
IPC分类号： A61K31/695 , C07D401/14 , A61K31/454 , C07F5/02 , A61K31/69 , C07D401/10 , C07D403/14 , A61K31/4178 , A61K31/496 , A61K31/506 , C07D413/14 , A61K31/5377 , A61K31/397 , C07F7/10 , A61P31/18
CPC分类号： C07F9/65583 , C07C33/26 , C07C201/06 , C07C205/19 , C07D207/08 , C07D207/09 , C07D207/16 , C07D401/14 , C07D403/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D453/00 , C07D471/04 , C07D491/113 , C07K5/06
摘要： Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
摘要翻译： 描述了有效抑制丙型肝炎病毒（“HCV”）复制的化合物。 本发明还涉及制备这种化合物的方法，包含这些化合物的组合物，以及使用这些化合物治疗HCV感染的方法。
-
公开(公告)号：US07875639B2
公开(公告)日：2011-01-25
申请号：US11755884
申请日：2007-05-31
申请人： Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
发明人： Alan S. Florjancic , Michael J. Dart , Keith B. Ryther , Arturo Perez-Medrano , William A. Carroll , Meena V. Patel , Karin Rosemarie Tietje , Tongmei Li , Teodozyj Kolasa , Megan E. Gallagher , Sridhar Peddi , Jennifer M. Frost , Derek W. Nelson
IPC分类号： A61K31/426 , A61K31/427 , A61K31/428 , A61K31/429 , C07D498/04 , C07D493/04 , C07D417/06 , C07D277/46 , C07D277/60 , C07D277/82
CPC分类号： C07D277/46 , A61K31/429 , C07D277/48 , C07D277/82 , C07D417/04 , C07D417/06 , C07D417/12 , C07D493/08 , C07D513/04
摘要： The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L2, are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译： 本发明涉及式（I）化合物或其药学上可接受的盐，前药，前体药物或其组合的盐，其中R1，R2，R3，R4和L2在说明书中定义，包含这些化合物的组合物， 以及使用这些化合物和组合物治疗病症和病症的方法。
-
公开(公告)号：US20100305109A1
公开(公告)日：2010-12-02
申请号：US12789744
申请日：2010-05-28
申请人： Marc J. Scanio , William H. Bunnelle , William A. Carroll , Sridhar Peddi , Arturo Perez-Medrano , Lei Shi
发明人： Marc J. Scanio , William H. Bunnelle , William A. Carroll , Sridhar Peddi , Arturo Perez-Medrano , Lei Shi
IPC分类号： A61K31/549 , C07D239/92 , A61K31/517 , C07D285/24 , A61P13/10 , A61P25/18 , A61P25/22 , A61P25/30 , A61P25/08 , A61P25/06
CPC分类号： C07D239/92 , C07D405/12 , C07D495/04
摘要： Disclosed herein are KCNQ potassium channels modulators of formula (I) wherein ring G1, X, R1, and R2 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.
摘要翻译： 本文公开了式（I）的KCNQ钾通道调节剂，其中环G1，X，R1和R2如说明书中所定义。 包含这些化合物的组合物; 还描述了使用这些化合物和组合物治疗病症和病症的方法。
-
-
-
-
-
-
-
-
-
搜索结果
86 条记录 (耗时 0.088 秒)
